Navigation Links
prGCD in Medical News

Protalix BioTherapeutics' prGCD Named One of the Five Most Promising Drugs Entering Phase III Trials by Thomson Scientific

CARMIEL, Israel, Dec. 3 /PRNewswire-FirstCall/ -- Protalix BioTherapeutics, Inc. (Amex: PLX ), noted today that prGCD, the Company's proprietary recombinant form of Glucocerebrosidase (GCD), which is used as an enzyme replacement therapy for Gaucher disease, was named one of the Five Most Pro...
prGCD in Medical Technology

Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD

First patient treated in trial of prGCD treatment of Gaucher Disease CARMIEL, Israel, Aug. 27 /PRNewswire-FirstCall/ -- Protalix BioTherapeutics, Inc. (Amex: PLX ), today announced that it has treated the first patient in its phase III clinical trial of the Company's lead product candidate,...

Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD

Phase III clinical trial may commence shortly CARMIEL, Israel, April 18, 2007 /PRNewswire-FirstCall/ --- Protalix BioTherapeutics, Inc. today announced that it has received written notice from the United States Food and Drug Administration (FDA) that it may initiate a Phase III clinical trial in t...
prGCD in Biological Technology

Protalix BioTherapeutics Signs Lease Agreement for Expansion of its Manufacturing and Research Facility in Carmiel, Israel

...ansion of the manufacturing facility, Yossi Maimon, the Company's Chief Financial Officer, said, "In light of the progress we have made to date in our prgcd program, we determined that we should commence the expansion of our current facility. Our expanded facility will provide us with the space and capacit...
Other Tags
(Date:11/21/2014)... First Choice Emergency Room ... new facility is located at 225 E. Parkwood Drive, ... are pleased to join the Friendswood community and look ... here,” said Dr. Siddiqi, Facility Medical Director of First ... the opening, First Choice Emergency Room made a donation ...
(Date:11/21/2014)... (PRWEB) November 21, 2014 M3 Global ... verified healthcare professional panel, today announced two important leadership changes ... Roni DasGupta as President of Market Research, Americas and the ... Europe. , Ms. DasGupta joined M3 in 2011 ... most recently Head of Sales. Roni has over 17 ...
(Date:11/21/2014)... By Dennis Thompson ... -- Overweight or obese women who get pregnant are much ... disease as an adult, new research suggests. But it ... in that trend, the researchers added. "Mothers who are ... study author Dr. Michael Mendelson. He is a research fellow ...
(Date:11/21/2014)... 20, 2014 (HealthDay News) -- Some people with cochlear ... internal magnet when they undergo an MRI scan, a ... by the researchers, about 300,000 people worldwide have cochlear ... people who are deaf or have severe hearing loss. ... with cochlear implants when undergoing MRI. One expert ...
(Date:11/21/2014)... By Serena Gordon ... -- Two U.S. government agencies have proposed new rules ... a clinical trial was successful or not. The ... required to publish summaries of their results to ClinicalTrials.gov -- ... of Health (NIH) and the U.S. Department of Health and ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Opens New Facility in Friendswood, Texas 2Health News:M3 Global Research Announces Leadership Team Promotions in US and EU 2Health News:Kids Born to Overweight Moms May Face Higher Heart Risks as Adults 2Health News:MRI Can Be Painful, Disruptive for People With Cochlear Implants 2Health News:U.S. Proposes Greater Public Access to Data From Clinical Trials 2
(Date:11/18/2014)... Nov. 17, 2014   News ... collaborate to develop The Partners Data Lake, an ... Partners Data Lake will allow researcher and clinicians ... treatment and the lives of patients , ... clinical activities across the Partners system, breaking down ...
(Date:11/18/2014)... NEW YORK , Nov. 18, 2014 /PRNewswire/ ... iris-based identity authentication solutions, and MorphoTrust USA ... solutions and services, today announced a strategic partnership ... across enterprise, motor vehicle administration (MVA), airport screening ... leader in identity-related solutions, MorphoTrust serves consumers through ...
(Date:11/12/2014)... 2014 Crossmatch™, a leading provider of biometric ... fingerprint readers have been deployed throughout Montparnasse Pasteleria, ... Mexico . The bakery chain implemented the Crossmatch ... caused by employees clocking in for each other. ... Montparnasse relied on paper timecards and a mechanical time ...
Breaking Biology News(10 mins):Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3Montparnasse Pasteleria Achieves Time and Attendance Transparency with Crossmatch U.are.U Fingerprint Readers 2
Other Contents